Ingevity Corp
For the period ended Dec 31, 2024. Filed Feb 19, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 19, 2025
NGVT$60.78-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Years Ended December 31, | |||
|---|---|---|---|
| In millions, except per share data | 2024 | 2023 | 2022 |
| Net sales | $1,406.4 | $1,692.1 | $1,668.3 |
| Cost of sales | 951.7 | 1,220.2 | 1,098.2 |
| Gross profit | 454.7 | 471.9 | 570.1 |
| Selling, general, and administrative expenses | 166.7 | 183.7 | 198.8 |
| Research and technical expenses | 28.1 | 31.8 | 30.3 |
| Restructuring and other (income) charges, net | 186.2 | 170.2 | 13.8 |
| Goodwill impairment charge | 349.1 | — | — |
| Acquisition-related costs | 0.3 | 3.6 | 5.0 |
| Other (income) expense, net | 169.8 | 5.7 | (1.7) |
| Interest expense | 97.8 | 93.3 | 61.8 |
| Interest income | (7.7) | (6.3) | (7.5) |
| Income (loss) before income taxes | (535.6) | (10.1) | 269.6 |
| Provision (benefit) for income taxes | (105.3) | (4.7) | 58.0 |
| Net income (loss) | $(430.3) | $(5.4) | $211.6 |
| Per share data | |||
| Basic earnings (loss) per share | $(11.85) | $(0.15) | $5.54 |
| Diluted earnings (loss) per share | (11.85) | (0.15) | 5.50 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.